DIMENSIONAL FUND ADVISORS LP - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$12,487,573
-13.4%
2,291,177
+6.6%
0.00%
-20.0%
Q2 2023$14,426,862
-0.9%
2,149,946
+30.4%
0.01%0.0%
Q1 2023$14,554,198
+186731.8%
1,648,361
+61.6%
0.01%
+150.0%
Q4 2022$7,790
-99.8%
1,019,739
+49.7%
0.00%0.0%
Q3 2022$4,848,000
+44.2%
681,077
+63.9%
0.00%
+100.0%
Q2 2022$3,361,000
-47.7%
415,484
-10.2%
0.00%
-50.0%
Q1 2022$6,425,000
-51.7%
462,924
-2.4%
0.00%
-50.0%
Q4 2021$13,315,000
+86.9%
474,508
+126.4%
0.00%
+100.0%
Q3 2021$7,124,000
+38.3%
209,606
+66.3%
0.00%0.0%
Q2 2021$5,151,000
-4.9%
126,057
-6.3%
0.00%0.0%
Q1 2021$5,414,000
+9.3%
134,492
+60.5%
0.00%0.0%
Q4 2020$4,955,000
+644.0%
83,791
+511.6%
0.00%
Q3 2020$666,000
-54.4%
13,700
-54.6%
0.00%
-100.0%
Q2 2020$1,461,000
+55.9%
30,206
-10.4%
0.00%
Q1 2020$937,00033,7230.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2021
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 3,030,434$20,334,21213.72%
BERYLSON CAPITAL PARTNERS, LLC 228,000$1,529,8804.32%
Eagle Health Investments LP 1,214,860$8,151,7111.52%
Matrix Capital Management Company, LP 11,572,590$77,652,0790.90%
Triatomic Management LP 121,166$813,0240.83%
VIKING GLOBAL INVESTORS LP 29,993,708$201,257,7810.82%
Aristotle Atlantic Partners, LLC 3,104,961$20,834,2880.78%
Pier Capital, LLC 737,589$4,949,2220.71%
ARK Investment Management 10,453,752$70,144,6750.46%
Nikko Asset Management Americas, Inc. 6,384,047$42,773,1150.45%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders